DE68926743D1 - Die freisetzung des histamin hemmenden faktors sowie diesen enthaltende präparate - Google Patents

Die freisetzung des histamin hemmenden faktors sowie diesen enthaltende präparate

Info

Publication number
DE68926743D1
DE68926743D1 DE68926743T DE68926743T DE68926743D1 DE 68926743 D1 DE68926743 D1 DE 68926743D1 DE 68926743 T DE68926743 T DE 68926743T DE 68926743 T DE68926743 T DE 68926743T DE 68926743 D1 DE68926743 D1 DE 68926743D1
Authority
DE
Germany
Prior art keywords
hrif
histamine
treatment
methods
cell lines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68926743T
Other languages
English (en)
Other versions
DE68926743T2 (de
Inventor
Rafeul Alam
J Grant
Michael Lett-Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Application granted granted Critical
Publication of DE68926743D1 publication Critical patent/DE68926743D1/de
Publication of DE68926743T2 publication Critical patent/DE68926743T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0642—Granulocytes, e.g. basopils, eosinophils, neutrophils, mast cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE68926743T 1988-01-12 1989-01-11 Die freisetzung des histamin hemmenden faktors sowie diesen enthaltende präparate Expired - Fee Related DE68926743T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14309488A 1988-01-12 1988-01-12
PCT/US1989/000104 WO1989006545A1 (en) 1988-01-12 1989-01-11 Histamine release inhibitory factor and preparations therefore

Publications (2)

Publication Number Publication Date
DE68926743D1 true DE68926743D1 (de) 1996-08-01
DE68926743T2 DE68926743T2 (de) 1997-01-09

Family

ID=22502579

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68926743T Expired - Fee Related DE68926743T2 (de) 1988-01-12 1989-01-11 Die freisetzung des histamin hemmenden faktors sowie diesen enthaltende präparate

Country Status (6)

Country Link
EP (1) EP0398924B1 (de)
AT (1) ATE139702T1 (de)
AU (1) AU2947889A (de)
CA (1) CA1334652C (de)
DE (1) DE68926743T2 (de)
WO (1) WO1989006545A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0540663A1 (de) * 1990-07-25 1993-05-12 Board Of Regents, The University Of Texas System Hemmung von cytokin-induzierter histaminfreisetzung von basophilen oder mastzellen mit interleukin 8
CN112899228B (zh) * 2021-02-04 2022-09-23 广州医科大学附属第一医院 一种从支气管肺泡灌洗液中分离提取细胞的方法

Also Published As

Publication number Publication date
EP0398924A1 (de) 1990-11-28
ATE139702T1 (de) 1996-07-15
DE68926743T2 (de) 1997-01-09
CA1334652C (en) 1995-03-07
WO1989006545A1 (en) 1989-07-27
EP0398924B1 (de) 1996-06-26
AU2947889A (en) 1989-08-11

Similar Documents

Publication Publication Date Title
ATE180255T1 (de) Guanidinderivate mit therapeutischer wirkung
DK1020179T3 (da) Peptidderivater eller farmaceutisk acceptable salte deraf, fremgangsmåde til fremstilling af de samme, anvendelse af derivaterne og farmaceutisk sammensætning
DK0559632T3 (da) Fremgangsmåde til fremstilling af vævsfaktorreaktionsvejsinhibitor
HUP9902698A2 (hu) Humán bikunin
KR950700333A (ko) 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes)
FI103506B1 (fi) Menetelmä syklisten aminohappojohdannaisten valmistamiseksi ja menetelmässä käytettävä välituote
EP0249736A3 (de) Salbe zur Behandlung von Hauterkrankungen
DK0396184T3 (da) Anvendelse af ketoconazol og et retinoid til behandling af acne vulgaris
MX9307983A (es) Derivados de aminoacidos de heterociclos como inhibidores de la proteina quinasa c.
ZA898605B (en) Compositions for topical treatment of skin diseases
KR900700495A (ko) 치료제로서 유용한 치환된 아데닌 유도체
DK0506836T3 (da) BCRF1 proteiner som inhibitorer for interferon-gamma
NO172043C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-2,3-butadienyl-triamioalkanderivater
DE69130679D1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
ES2039196T3 (es) Procedimiento para preparar 4-(1,2,5,6-tetrahidro-1-alquil-3-piridinil)-2-tiazolaminas y 4-(hexahidro-1-alquil-3-piridinil)-2-tiazolaminas.
DE68926743D1 (de) Die freisetzung des histamin hemmenden faktors sowie diesen enthaltende präparate
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
HUP0003357A2 (hu) Angiogén hatású ciklusos azapeptidek, ezeket hatóanyagként tartalmazó gyógyászati készítmények, eljárás ezek előállítására és alkalmazásuk
MX9202366A (es) Nuevas 2-amino-5-ciano-1,4-di hidro piridinas y procedimiento para su fabricacion.
IE870577L (en) Topical amide preparation
FI93843B (fi) Menetelmä angiogeenisen tekijän tuottamiseksi
DK0505400T3 (da) N-substituerede naphthalimider, deres fremstilling og anvendelse
IT1097897B (it) Derivati del piranocromone e composizione terapeutica comprendente gli stessi,per il trattamento di malattie allergiche
SE8200748L (sv) Terapeutiskt medel
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee